Stroke is the third-leading cause of death and a major
|
|
- Gerald O’Brien’
- 5 years ago
- Views:
Transcription
1 Long-Term Mortality and Recurrent Stroke Risk Among Chinese Stroke Patients With Predominant Intracranial Atherosclerosis Ka Sing Wong, MD; Huan Li, MD Background and Purpose The goal of this study was to document the long-term outcome of ischemic stroke patients in a population with predominant intracranial atherosclerosis and risk factors for a recurrent event. Methods Intracranial and extracranial arteries of consecutive patients with acute ischemic stroke were studied prospectively with transcranial Doppler and duplex ultrasound. All patients were followed up regularly for the development of recurrent stroke, cardiac event, or death. Results We included 705 patients with acute ischemic stroke, of whom 345 were documented ultrasonographically as having large-artery lesions. The follow-up period was up to 42 months (mean, 28 5 months). One hundred seventeen patients (17%) died of any cause, and 199 (28%) suffered further cerebrovascular cardiac events. The 3.5-year cumulative mortality rate was 20.8%; for cerebrovascular event, it was 29.5%. The annual recurrent stroke rates during the first year were 10.9% for patients without vascular lesion, 17.1% for intracranial atherosclerosis only, and 24.3% for both intracranial and extracranial atherosclerosis; for the second year, the rates were 7.5%, 8.6%, and 7.7%, respectively. More occurrence of death (log rank, 5.19; P 0.02) or cerebrovascular event (log rank, 9.68; P 0.002) was found among patients with than those without vascular lesions. Patients with both intracranial and extracranial arterial lesions were at highest risk of death (log rank, 9.64; P 0.008) and cerebrovascular event (log rank, 11.56; P 0.003). When death and further vascular event were combined as poor outcomes in a Cox proportional-hazards regression model, number of abnormal arteries, advanced age, diabetes, atrial fibrillation, and previous stroke were significant predictors. Conclusions Patients with intracranial atherosclerosis, especially coexisting extracranial carotid disease, are at higher risk of suffering death or further vascular event. Our findings provide important data for planning future randomized clinical trials for this high-risk group of stroke patients. (Stroke. 2003;34: ) Key Words: epidemiology intracranial arteriosclerosis prognosis stroke ultrasonography, Doppler, transcranial Stroke is the third-leading cause of death and a major cause of disability in adults, and it is often more disabling than fatal. Primary stroke prevention programs such as traditional risk factor reduction have achieved a reduction in the number of incident strokes. However, with a decline in mortality from initial cerebral infarction and an increase in the life expectancy of the population, the number of patients with recurrent stroke and subsequent cardiovascular events will become greater. Thus, it is important to identify those stroke patients at high risk for stroke recurrence and death. Carotid atherosclerotic stenosis has been listed as an important risk factor for stroke. 1,2 In contrast, intracranial atherosclerosis is not often mentioned as a risk factor associated with recurrent stroke. This is due in part to the lack of long-term outcome data of intracranial atherosclerosis. This study aimed at documenting the annual risk of recurrent stroke and mortality among patients with intracranial atherosclerosis. The short-term outcomes were reported earlier. 3 Subjects and Methods The present study was performed at the Prince of Wales Hospital in Hong Kong, a regional general hospital with accident and emergency services. The protocol was approved by the Clinical Research Ethics Committee of the Chinese University of Hong Kong. In this prospective study, we recruited consecutive patients presented with cerebral ischemia within 7 days of symptom onset. The methods were described in detail in an earlier publication, which also described the short-term outcome. 3 Briefly, we recruited patients admitted with acute cerebral ischemia, including transient ischemic attack (TIA) and cerebral infarct. All patients underwent a CT scan to rule out intracranial hemorrhage. On admission, baseline data, including age, sex, medical history, and physical examination, were collected. Scoring of prestroke disability was estimated with the modified Rankin scale (mrs), and severity of neurological deficits of index stroke was assessed with the National Institutes of Health Stroke Scale (NIHSS). Vascular risk factors were noted, particularly Received December 5, 2002; final revision received April 22, 2003; accepted May 20, From the Division of Neurology, Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong, SAR. Correspondence to Dr Ka Sing Wong, Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, SAR. ks-wong@cuhk.edu.hk 2003 American Heart Association, Inc. Stroke is available at DOI: /01.STR A 2361
2 2362 Stroke October 2003 in patients with any history of smoking, hypertension, diabetes mellitus, ischemic heart disease, atrial fibrillation, and previous TIA or stroke. Blood biochemistry, blood count test, ECG, and chest x-ray were checked routinely. Transcranial Doppler (TCD) examination was performed on each enrolled patient to document the cerebral arterial condition within 1 week of symptom onset. Using a standardized protocol based on a principle previously described, 4 we studied the intracranial large arteries through the temporal, occipital, and orbital windows. Briefly, we examined the following arteries in 4-cm increments: middle cerebral artery, anterior cerebral artery, posterior cerebral artery, siphon internal carotid artery, and vertebrobasilar artery. We also examined the bilateral extracranial carotid arteries. The diagnostic criteria for arterial stenosis or occlusion were given earlier. 3 Cerebral arteries that could not be insonated because of poor temporal acoustic windows were regarded as nonocclusive. All survivors were followed up regularly by telephone or personal interview, in addition to routine medical outpatient clinic attendance. If patients could not be reached at this follow-up, we found their medical records and tried to contact their relatives for more information about the patient s condition. All telephone and personal interviews were performed by a stroke specialty nurse using a standardized questionnaire. The specified outcomes were defined as occurrence of a further vascular event (including TIA, stroke, or acute coronary syndrome) or death. The long-term combined poor outcome was regarded as occurrence of either death or a further vascular event. If death and a further vascular event (supposed cause of death) were recorded as occurring simultaneously, 1 event was categorized into the analysis. For example, if a patient died of acute myocardial infarction, we regarded the event as death in the mortality analysis and as a further vascular event in the further-vascular-event analysis. The nature of the vascular event and the cause of death were based on medical records and death certificates when possible. Recurrent events were based of the diagnosis on the discharge summary according to the treating physician. The definite and detailed description of the cause of death by the patient s relative was used if the cause could not be obtained by other means. Obscure or indefinite information about cause of death was classified as unknown cause. Statistic Analysis All data were entered into the SPSS software (version 9.0 for Windows) for storage and analysis. GraphPad InStat software (version 3.02 for Windows) was used as a complementary way to perform a 2 test of a larger contingency table. Statistical significance was considered at P 0.05 and was 2 sided. In the present study, age and number of occlusive arteries were used as continuous variables. Sex, vascular risk factors, and end points of long-term outcome were used as categorical variables. We also categorized the scores of mrs and NIHSS as categorical variables. The scores of mrs were dichotomized as 0 to 2 and 3 to 5, and NIHSS scores were grouped as 0 to 1, 2 to 8, and 9. In univariate analyses, independent-sample t test and 2 test or Fisher s exact test was used. We also applied the 2 test for trend to explore the relationship between the number of occlusive arteries and occurrence of a further vascular event or death. In analyses of predictors of the long-term clinical outcome, Cox proportionalhazards regression function was used to estimate impact in terms of risk ratios of possible determinants of survival and further vascular events, taking the time variable into consideration. Hazard ratio (HR), 95% confidence interval (CI), and probability value were observed. In survival analyses, the Kaplan-Meier product-limit method was used to estimate survival condition. The log-rank test was used to compare rate estimates. Results A total of 705 patients admitted with acute cerebral ischemia were recruited. Their mean age on admission of index stroke was years, with 67% 65 years of age; 58% (409 patients) were men. Vascular risk factors were common among these patients. Hypertension (58%), history of smoking (44%), and previous stroke or TIA (33%) were the 3 most common vascular risk factors. Atrial fibrillation was found in 38 patients (5%). Of 705 patients, 345 patients (49%) were documented ultrasonographically with cerebral arterial lesions in the initial TCD examination; the other 360 (51%) had no vascular lesion identified. Among the 345 patients with vascular lesions, 258 (75%) had intracranial vascular lesions only, 71 (21%) had both intracranial and extracranial lesions, and 16 (4.6%) had extracranial lesions only. The clinical characteristics of patients were reported in detail previously. 3 We followed up this cohort for a mean period of 28 5 months (up to 42 months) after stroke onset. Fourteen patients (2%) were lost to follow-up at the end of the study and could not be reached. The duration between the index stroke and last contact date of these 14 patients ranged from 6.3 to 17.8 months. In 8 patients, we had follow-up data of 1 year after the index stroke. A total of 117 patients (17%) died of any cause (including vascular and nonvascular), and 199 patients (28%) suffered a further vascular event (including fatal and nonfatal). Overall, 691 patients survived the index stroke, with 448 patients alive free of a further vascular event. At the end of follow-up, 85% of patients remained on regular antiplatelet agent (78.5%) or anticoagulant (6.2%). The remaining 15% were not on any antithrombotic treatment mainly because of bleeding contraindications such as gastrointestinal bleeding and intracerebral hemorrhage, which were common in Chinese patients. Occurrence of Death Among the 117 patients who died, 59 patients (50.4%) died of vascular causes (including 43 patients of further vascular events and 14 of the index stroke), and 32 patients (27.4%) died of unknown causes. Cerebrovascular events were more commonly the cause of death than cardiac events (27 versus 18, respectively). Table 1 shows the detailed underlying causes of death. Of the 705 patients, the 3.5-year cumulative mortality rate was 20.8% (95% CI, 16 to 25.6) by the Kaplan-Meier product limit method. The cumulative mortality rate was 5.7% (95% CI, 4 to 7.4) at 6 months, 8.9% (95% CI, 6.8 to 11.0) by 1 year, 14.9% (95% CI, 12.2 to 17.6) by 2 years, and 20.8% (95% CI, 16 to 25.6) by 4 years. The risk of death was greatest in the first year, especially at 6 months, and decreased over the next 2 years (Table 2). Slightly more deaths were found among patients with vascular lesions (66 of 345 patients, 19%) than those without (51 of 360 patients, 14%). Considering the number of occlusive arteries, the higher occurrence of death was found among patients with more arterial involvement (P 0.02 by 2 test for trend). The cumulative mortality rate was 7.2% (95% CI, 4.5 to 9.9) by 1 year, 12.4% (95% CI, 9.0 to 15.8) by 2 years, and 15.9% (95% CI, 11.5 to 20.3) by 3 years for patients without vascular lesion and 11% (95% CI, 7.7 to 14.3), 17.8% (95% CI, 13.6 to 22.0), and 32.4% (95% CI, 15.6 to 49.2), respectively, for patients with vascular lesions. The Kaplan-Meier product limit survival function showed a significantly higher mortality rate for patients with than for those without vascular lesions (log rank, 5.19; P 0.02). In
3 Wong and Li Long-Term Outcome for Intracranial Atherosclerosis 2363 TABLE 1. Underlying Causes of Death Neurovascular Ultrasonographic Results, n (%) Vascular Lesion Vascular Lesion Total, Cause of Death* Absent Present n (%) Vascular cause 18 (15.4) 41 (35) 59 (50.4) Index stroke 5 9 Recurrent stroke (ischemic) 4 10 Recurrent stroke (hemorrhagic) 5 8 Acute coronary syndrome 4 13 Rupture of aortic aneurysm 0 1 Nonvascular 10 (8.5) 16 (13.7) 26 (22) Gastrointestinal bleeding 1 3 Congestive heart failure 1 2 Renal failure 0 1 Carcinoma 3 8 Pneumonia/sepsis 4 2 Pulmonary embolism 1 0 Unknown 23 (20) 9 (7.7) 32 (27.4) Total 51 (44) 66 (56) 117 (100) *May not be the first vascular event after stroke. addition, patients with atrial fibrillation also showed a significantly higher mortality rate than those without atrial fibrillation during the long-term follow-up (log rank, 22.4; P ). Taking the extracranial and intracranial distribution of arterial lesions into consideration, we found that patients with both intracranial and extracranial arterial lesions had the highest mortality rate (log rank, 9.64; P by Kaplan-Meier product limit survival function; Figure 1A and Table 2). Because a small number of patients (n 16) had extracranial carotid lesions only, we excluded these patients in this analysis. Univariate analysis showed that age (P ), atrial fibrillation (P ), and number of occlusive arteries (P 0.02) were related to long-term mortality. After adjustment for age, sex, prestroke mrs, NIHSS, hypertension, diabetes, smoking, ischemic heart disease, atrial fibrillation, previous stroke or TIA, and number of occlusive arteries, number of occlusive arteries (HR, 1.16; 95% CI, 1.06 to 1.28; P 0.002) remained the significant predictor of long-term mortality in Cox proportional-hazard regression model. Other independent predictors included advanced age (HR, 1.08; TABLE 2. Annual Risk of Death and Cerebrovascular Event After Stroke Annual Risk of Death, % Annual Risk of Cerebrovascular Event, % Vascular Lesion Year 1 Year 2 Year 1 Year 2 Absent (n 360) Intracranial only (n 258) Both intracranial and extracranial (n 71) Total (n 705) % CI, 1.05 to 1.10; P ) and atrial fibrillation (HR, 2.16; 95% CI, 1.25 to 3.73; P 0.006). Occurrence of Further Vascular Event Of the 705 patients, a first major vascular event after index stroke occurred among 199 patients (28%). The major vascular events included 33 TIAs, 120 strokes, and 46 acute coronary syndromes. Of 199 further vascular events, 38 were fatal, including 22 cerebrovascular events and 16 acute coronary syndromes (Table 3). Cerebrovascular events (including TIA and stroke) accounted for 77% of 199 further vascular events. The estimated 3.5-year cumulative rate of cerebrovascular event was 29.5% (95% CI, 23 to 36) by the Kaplan-Meier product limit method. The cumulative cerebrovascular event rate was 8.8% (95% CI, 6.7 to 10.9) at 6 months, 13.7% (95% CI, 11.1 to 16.3) by 1 year, 21.2% (95% CI, 18.0 to 24.2) by 2 years, and 29.5% (95% CI, 23 to 36) by 3 years. The risk of developing a further cerebrovascular event was greatest in the first year, especially the first 6 months, after a stroke. The annual rate of cerebrovascular event tended to decrease over 2 years (Table 2). Significantly more patients with than without vascular lesions suffered a further cerebrovascular event (88 versus 65, P 0.02 by 2 test). Considering the number of occlusive arteries, a greater occurrence of death was found among patients with more arterial involvement (P by 2 test for trend) The cumulative rate of cerebrovascular event was 10.9% by 1 year, 17.6% by 2 years, and 21.2% by 3 years for patients without vascular lesions and 17.4%, 25.0%, and 46.8%, respectively, for patients with vascular lesions. The Kaplan- Meier product limit survival function showed a significantly higher rate of occurrence of cerebrovascular event in patients with than in those without vascular lesions (log rank, 9.68;
4 2364 Stroke October 2003 Survival stratified by distribution of arterial lesions (A; n 689) and free of a cerebrovascular event stratified by distribution of arterial lesions (B; n 689). Solid line represents normality of intracranial and extracranial arteries; dashed line, abnormality of intracranial arteries only; and dotted line, abnormality of intracranial and extracranial arteries. P 0.002). Taking the vascular lesion distribution into account, we found patients with both intracranial and extracranial arterial lesions had the highest cerebrovascular event rate (log rank, 11.56; P by Kaplan-Meier product limit survival function; Figure 1B and Table 3). Survival function also showed that the occurrence of a further cerebrovascular event during long-term follow-up was significantly high among patients with a history of diabetes (log rank, 4.24; P 0.04), atrial fibrillation (log rank, 4.06; P 0.04), and previous stroke or TIA (log rank, 13.29; P ). Univariate analysis showed that age (P 0.03), previous stroke or TIA (P ), and number of occlusive arteries (P 0.004) were related to long-term occurrence of further cerebrovascular event. After adjustment in a Cox proportional-hazards regression model, number of occlusive arteries (HR, 1.15; 95% CI, 1.06 to 1.25; P ), age (HR, 1.02; 95% CI, 1.00 to 1.03; P 0.02), atrial fibrillation (HR, 1.98; 95% CI, 1.05 to 3.72; P 0.03), and previous stroke or TIA (HR, 1.68; 95% CI, 1.21 to 2.33; P 0.002) were predictive of further cerebrovascular event. Predictors for Combined Poor Outcome Both death and subsequent vascular event represent poor outcomes after stroke. When death and subsequent vascular event were combined, a total of 259 patients (37%) of the cohort suffered a poor outcome. The poor outcomes included 26 deaths resulting from nonvascular causes (3.7%), 27 deaths resulting from recurrent stroke (3.8%), 18 deaths resulting from coronary events (2.6%), 14 deaths resulting from index stroke (2%), 32 deaths of unknown causes (4.5%), and 142 subjects alive with subsequent vascular events (20%). The occurrence of combined poor outcome increased notably with an increase in number of occlusive arteries (P by 2 for trend). Univariate analysis showed that occurrence of combined poor outcome was associated with advanced age (P ), history of diabetes (P 0.03), ischemic heart disease (P 0.03), atrial fibrillation (P ), and previous stroke or TIA (P 0.02). No association was found between longterm poor outcome and severity of index stroke, sex, hypertension, and smoking history. After adjustment for a total of 11 variables (age, sex, prestroke mrs, NIHSS, history of hypertension, diabetes, ischemic heart disease, atrial fibrillation, smoking, previous stroke or TIA, and number of occlusive arteries) in a multivariate Cox proportional-hazards regression model, the number of abnormal arteries (HR, 1.13; 95% CI, 1.05 to 1.20; P ) remained significantly predictive for long-term combined poor outcome, as were advanced age (HR, 1.03; 95% CI, 1.02 to 1.04; P ), diabetes (HR, 1.34; 95% CI, 1.01 to 1.77; P 0.04), atrial fibrillation (HR, 2.68; 95% CI, 1.77 to 4.07; P ), and previous stroke or TIA (HR, 1.30; 95% CI, 1.00 to 1.68; P 0.04). Table 4 summarizes the predictors for long-term combined poor outcome. Discussion There has been no large prospective study on mortality rate and recurrence among stroke patients with intracranial atherosclerosis. Intracranial large-artery occlusive disease has been reported to be more predominant in Chinese than white stroke patients. 5 8 This study is the largest prospective study to take into consideration the intracranial and extracranial distribution of vascular lesions. We attempted to document long-term prognosis and significance of distribution of largeartery occlusive disease on mortality and recurrence. Patients with vascular lesions had a higher mortality rate and a higher risk of a further vascular event than patients without vascular lesions. Patients with both intracranial and extracranial vascular lesions had a significantly worse outcome than patients with intracranial lesions only. Furthermore, in a multivariate Cox proportional-hazards regression model, the risk of death, subsequent cerebrovascular event, or acute coronary syndrome after stroke increased significantly with 1 more arterial involvement (HR, 1.16; 95% CI, 1.06 to 1.28). Our finding is in agreement with a meta-analysis 9 that documented that patients with intracranial carotid stenosis or occlusion had a higher rate of recurrent stroke (rate ratio, 1.09; 95% CI, 1.05 to 1.14) or vascular mortality (rate ratio, 1.10; 95% CI, 1.06 to 1.14). Because most patients (85%) were on antiplatelet medication or an anticoagulant agent, a more effective
5 Wong and Li Long-Term Outcome for Intracranial Atherosclerosis 2365 TABLE 3. Type of Further Vascular Event Neurovascular Ultrasonographic Result, n (%) Vascular Lesion Vascular Lesion First Vascular Event Absent Present Total, n (%) Nonfatal 78 (39) 83 (42) 161 (81) TIA Recurrent stroke (ischemic) Recurrent stroke (hemorrhagic) 7 7 Acute coronary syndrome Fatal 10 (5) 28 (14) 38 (19) Recurrent stroke (ischemic) 4 10 Recurrent stroke (hemorrhagic) 3 5 Acute coronary syndrome 3 12 Rupture aortic aneurysm 0 1 Total 88 (44) 111 (56) 199 (100) therapy for stroke patients with cerebrovascular lesions needs to be explored. The high rate of recurrent events could not be accounted for by the differences in the use of antithrombotic treatment. On the contrary, significantly more patients with vascular lesions (314 of 345, 91%) were on antithrombotic treatment than those without vascular lesions (285 of 360, 79.2%; P ). The present study of Chinese patients showed that the cumulative mortality rate after stroke is 5.7% at 6 months, 8.9% within the first year, 14.9% by 2 years, and 20.8% by 3 years. Our data showed that patients with intracranial or tandem atherosclerosis are at the greatest risk of stroke or death within the first 6 months of a stroke. Thus, early and aggressive therapy may be needed to prevent these adverse events in this high-risk group of patients. TABLE 4. Predictors of Death or Further Vascular Event Unadjusted OR (95% CI) P Besides the number of occlusive arteries, advancing age and atrial fibrillation were powerful independent predictors of death and recurrent events among our patients. This observation was well established, but we found that even when these 2 important factors were taken into account, the number of occlusive vessels remained an independent predictor. The strengths of our study are the large number of patients and the small number lost to follow-up. The weakness is the lack of angiographic study to confirm the diagnosis of occlusive disease. However, it would be impossible to conduct a large study with intravenous conventional angiography because of the cost and risk associated with this procedure. TCD may not be ideal, but it is accessible for most hospitals (especially important for rural hospitals in developing countries), has a low cost, is safe, and is well accepted by patients. Adjusted OR (95% CI) P Age 1.03 ( ) * 1.03 ( ) * Sex Men Women 0.94 ( ) ( ) 0.46 Prestroke MRS ( ) ( ) NIHSS score ( ) ( ) ( ) ( ) Risk factors Smoking 1.04 ( ) ( ) 0.81 Hypertension 1.21 ( ) ( ) 0.65 Diabetes mellitus 1.34 ( ) 0.03* 1.34 ( ) 0.04* Ischemic heart disease 1.50 ( ) 0.03* 1.06 ( ) 0.76 Atrial fibrillation 3.10 ( ) * 2.68 ( ) * Prior stroke or TIA 1.37 ( ) 0.02* 1.30 ( ) 0.05* Number of occlusive arteries 1.13 ( ) * 1.13 ( ) * *Difference reached significance level.
6 2366 Stroke October 2003 TCD is an accepted method for diagnosing intracranial occlusive disease and has been validated for grading middle cerebral artery stenosis. 10,11 Many studies of long-term outcomes of stroke patients reported recurrent events among the survivors of the index stroke. Nowadays, however, many secondary prevention therapies such as aspirin, warfarin, and statin are initiated soon after stroke before discharge from hospital, so we used a pragmatic approach to reporting all deaths and vascular events after the index stroke. Furthermore, some patients died of stroke complications from the index stroke after hospital discharge, and it might be difficult to have a cutoff time for categorizing survival and death. Although this study was hospital based, our hospital was the one with emergency admission and captured 95% of all hospital admissions in our region. In addition, most patients with stroke required hospital admission for investigations such as CT scan in Hong Kong. In this study, we used TCD as the only diagnostic tool for intracranial occlusive disease. Regardless of known and accepted TCD criteria for intracranial stenotic disease, TCD is largely operator dependent. Additionally, turbulent flow resulting from anatomic variations in vessel size and course, inability to make angle corrections for the ultrasound beam, and poor acoustic windows are major limitations of TCD. Ideally, angiography such as digital subtraction, MRA, or CTA should be done in those patients with a poor temporal window. Unfortunately, lack of resources in the present study prevented us from performing angiography in our patients. Future studies should consider the use of supplementary angiography to rectify this weakness. Moreover, flow velocities vary significantly with age and presence of vascular risk factors and during the course of the acute phase of stroke. However, even with these limitations, we were able to detect significant differences with the use of TCD only. Further studies using additional diagnostic tests such as angiography may require fewer patients to document the poor prognosis of patients with intracranial occlusive disease. In our laboratory, the TCD criteria used in this study have a sensitivity of 91.4% and a specificity of 82.7% for diagnosing 50% middle cerebral artery stenosis compared with MR angiography. 11 The TCD assessments were performed within 7 days of symptom onset. In the acute stroke settings, TCD results may be significantly influenced by the time from stroke onset. The TCD results might have been misinterpreted in terms of hemodynamic changes (stenosis versus recanalization, compensatory flow, collateral circulation) or cause of stroke (embolic versus intracranial stenosis). A significant number of these intracranial atherosclerotic lesions may be of cardioembolic origin. In this study, only 38 patients had known cardioembolism such as atrial fibrillation (5%). Furthermore, we have found that 7% of asymptomatic community subjects 40 years of age have intracranial stenosis, indicating that intracranial disease is common in our population. 12 More than 70% of patients with occlusive disease in the middle cerebral artery had persistent disease after 6 months. 13 Persistent TCD abnormalities would be more likely to be due to intracranial atherosclerosis. In summary, our study provided important epidemiological data on poststroke mortality and recurrence rate among our population with a preponderance of intracranial atherosclerosis. Patients with intracranial atherosclerosis are at higher risk than those without intracranial atherosclerosis. Moreover, patients with both intracranial and extracranial occlusive diseases have the worst outcome. Acknowledgment This study was supported by a grant from the Research Grants Council of Hong Kong (grant CUHK 4341/98M). References 1. Gorelick PB, Sacco RL, Smith DB, Alberts M, Mustone-Alexander L, Rader D, Ross JL, Raps E, Ozer MN, Brass LM, et al. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA. 1999;281: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285: Wong KS, Li H, Chan YL, Ahuja A, Lam W, Wong A, Kay R. Use of transcranial Doppler ultrasound to predict prognosis in patients with intracranial large artery occlusive disease. Stroke. 2000;31: Babikian VL, Wechsler LR. Transcranial Doppler Ultrasonography. St Louis, Mo: Mosby-Year Book, Inc; Feldmann E, Daneault N, Kwan E, Ho KJ, Pessin MS, Langenberg P, Caplan LR. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology. 1990;40: Thajeb P. Large vessel disease in Chinese patients with capsular infarcts and prior ipsilateral transient ischaemia. Neuroradiology. 1993;35: Huang YN, Gao S, Li SW, Huang Y, Li JF, Wong KS, Kay R. Vascular lesions in Chinese patients with transient ischemic attacks. Neurology. 1997;48: Wong KS, Huang YN, Gao S, Lam WW, Chan YL, Kay R. Intracranial stenosis in Chinese patients with acute stroke. Neurology. 1998;50: Klijn CJM, Kappelle LJ, Algra A, Van Gijn J. Outcome in Patients with symptomatic occlusion of the internal carotid artery or intracranial arterial lesions: a meta-analysis of the role of baseline characteristics and types of antithrombotic treatment. Cerebrovasc Dis. 2001;12: Babikian VL, Feldmann E, Wechsler LR, Newell DW, Gomez CR, Bogdahn U, Caplan LR, Spencer MP, Tegeler C, Ringelstein EB, Alexandrov AV. Transcranial Doppler ultrasonography: year 2000 update. J Neuroimaging. 2000;10: Gao S, Lam WWM, Chan YL, Liu JY, Wong KS. The optimal values of flow velocity on transcranial Doppler in grading middle cerebral artery stenosis in comparison with magnetic resonance angiography. J Neuroimaging. 2002;12: Wong KS, Huang YN, Yang HB, Li H, Gao S. Prevalence of intracranial large artery stenosis in China: a population-based study. Stroke. 2000; 31:2793. Abstract. 13. Wong KS, Li H, Lam WMM, Chan YL, Kay R. Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke. Stroke. 2002;33:
Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on
6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor
More information2/7/
Disclosure Intracranial Atherosclerosis an update None Mai N. Nguyen-Huynh, MD, MAS Assistant Professor of Neurology UCSF Neurovascular Service February 7, 2009 Case #1 60 y.o. Chinese-speaking speaking
More informationIn cerebral infarction, the prognostic value of angiographic
Nonrelevant Cerebral Atherosclerosis is a Strong Prognostic Factor in Acute Cerebral Infarction Jinkwon Kim, MD; Tae-Jin Song, MD; Dongbeom Song, MD; Hye Sun Lee, MS; Chung Mo Nam, PhD; Hyo Suk Nam, MD,
More informationDistribution of intracranial vascular lesions in the posterior circulation among Chinese stroke patients
Neurol J Southeast Asia 2002; 7 : 65 69 ORIGINAL ARTICLES Distribution of intracranial vascular lesions in the posterior circulation among Chinese stroke patients Huan LI MD, *Wynnie WM LAM FRCR, Ka Sing
More informationIntracranial Atherosclerosis in Asians
Intracranial Atherosclerosis in Asians Anthony S. Kim, MD Assistant Clinical Professor of Neurology UCSF Neurovascular Service February 27, 2010 Disclosures Research Support National Institutes of Health
More informationAPPENDIX A NORTH AMERICAN SYMPTOMATIC CAROTID ENDARTERECTOMY TRIAL
APPENDIX A Primary Findings From Selected Recent National Institute of Neurological Disorders and Stroke-Sponsored Clinical Trials That Have shaped Modern Stroke Prevention Philip B. Gorelick 178 NORTH
More informationCanadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management
Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:
More informationCarotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO
Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent
More informationClinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease
Cronicon OPEN ACCESS EC NEUROLOGY Research Article Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Jin Ok Kim, Hyung-IL Kim, Jae Guk Kim, Hanna Choi, Sung-Yeon
More informationPrevalence and Risk Factors of Intracranial Atherosclerosis in an Asymptomatic Korean Population
Journal of Clinical Neurology / Volume 2 / March, 2006 Prevalence and Risk Factors of Intracranial Atherosclerosis in an Asymptomatic Korean Population Kwang-Yeol Park, M.D., Chin-Sang Chung, M.D., Ph.D.,
More informationSlide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure
Slide 1 The Treatment of Intracranial Stenosis Helmi Lutsep, MD Vice Chair and Dixon Term Professor, Department of Neurology, Oregon Health & Science University Chief of Neurology, VA Portland Health Care
More informationLesion Patterns and Stroke Mechanisms in Concurrent Atherosclerosis of Intracranial and Extracranial Vessels
Lesion Patterns and Stroke Mechanisms in Concurrent Atherosclerosis of Intracranial and Extracranial Vessels Bik Ling Man, MD; Yat Pang Fu, MD; Yin Yan Chan, MD; Wynnie Lam, MD; Andrew Chi Fai Hui, MD;
More informationAntithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)
Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase
More informationISPUB.COM. Transcranial Doppler: An Overview of its Clinical Applications. A Alexandrov, M Joseph INTRODUCTION SICKLE CELL DISEASE
ISPUB.COM The Internet Journal of Neuromonitoring Volume 1 Number 1 Transcranial Doppler: An Overview of its Clinical Applications A Alexandrov, M Joseph Citation A Alexandrov, M Joseph. Transcranial Doppler:
More informationTransient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction
Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction Doron Aronson MD, Gregory Telman MD, Fadel BahouthMD, Jonathan Lessick MD, DSc and Rema Bishara MD Department of Cardiology
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Xian Y, Liang L, et al. Association of intracerebral hemorrhage among patients taking non vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital
More informationOriginal Contributions. Prospective Comparison of a Cohort With Asymptomatic Carotid Bruit and a Population-Based Cohort Without Carotid Bruit
98 Original Contributions Prospective Comparison of a Cohort With Carotid Bruit and a Population-Based Cohort Without Carotid Bruit David O. Wiebers, MD, Jack P. Whisnant, MD, Burton A. Sandok, MD, and
More informationStroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013
Stroke 101 Maine Cardiovascular Health Summit Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013 Stroke Statistics Definition of stroke Risk factors Warning signs Treatment
More informationDiagnosis of Middle Cerebral Artery Occlusion with Transcranial Color-Coded Real-Time Sonography
Diagnosis of Middle Cerebral Artery Occlusion with Transcranial Color-Coded Real-Time Sonography Kazumi Kimura, Yoichiro Hashimoto, Teruyuki Hirano, Makoto Uchino, and Masayuki Ando PURPOSE: To determine
More informationIntroduction. Keywords: Infrainguinal bypass; Prognosis; Haemorrhage; Anticoagulants; Antiplatelets.
Eur J Vasc Endovasc Surg 30, 154 159 (2005) doi:10.1016/j.ejvs.2005.03.005, available online at http://www.sciencedirect.com on Risk of Major Haemorrhage in Patients after Infrainguinal Venous Bypass Surgery:
More informationThe Impact of Smoking on Acute Ischemic Stroke
Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease
More informationCHAPTER 5. Symptomatic and Asymptomatic Retinal Embolism Have Different Mechanisms
CHAPTER 5 Symptomatic and Asymptomatic Retinal Embolism Have Different Mechanisms Christine A.C. Wijman, Joao A. Gomes, Michael R. Winter, Behrooz Koleini, Ippolit C.A. Matjucha, Val E. Pochay, Viken L.
More informationCarotid Revascularization
Options for Carotid Disease Carotid Revascularization Wayne Causey, MD 2 nd Year Vascular Surgery Fellow Best medical therapy, Carotid Endarterectomy, and Carotid Stenting Who benefits from best medical
More informationDisclosures. An Update on TIA and Minor Stroke. The Agenda PROGNOSIS PATHOPHYSIOLOGY GUIDELINES AND PROVEN MANAGEMENT STRATEGIES AGGRESSIVE TREATMENT
Disclosures An Update on TIA and Minor Stroke Dr. Johnston is principal investigator for the POINT trial, sponsored by the NIH but with drug and placebo contributed by Sanofi-Aventis. S. Claiborne Johnston,
More informationCLINICAL FEATURES THAT SUPPORT ATHEROSCLEROTIC STROKE 1. cerebral cortical impairment (aphasia, neglect, restricted motor involvement, etc.) or brain stem or cerebellar dysfunction 2. lacunar clinical
More informationReduction of flow velocities in patients with ischemic events in the middle cerebral artery long-term follow-up with ultrasound
Acta Neurol. Belg., 20,, -5 Original articles Reduction of flow velocities in patients with ischemic events in the middle cerebral artery long-term follow-up with ultrasound Christine Kremer and Kasim
More informationEmergency Department Stroke Registry Process of Care Indicator Specifications (July 1, 2011 June 30, 2012 Dates of Service)
Specifications Description Methodology NIH Stroke Scale (NIHSS) Performed in Initial Evaluation used to assess the percentage of adult stroke patients who had the NIHSS performed during their initial evaluation
More informationTHE incidence of stroke after noncardiac surgery
Lack of Association between Carotid Artery Stenosis and Stroke or Myocardial Injury after Noncardiac Surgery in High-risk Patients ABSTRACT Background: Whether carotid artery stenosis predicts stroke after
More informationMichael Horowitz, MD Pittsburgh, PA
Michael Horowitz, MD Pittsburgh, PA Introduction Cervical Artery Dissection occurs by a rupture within the arterial wall leading to an intra-mural Hematoma. A possible consequence is an acute occlusion
More informationORIGINAL CONTRIBUTION. Early Stroke Risk After Transient Ischemic Attack Among Individuals With Symptomatic Intracranial Artery Stenosis
ORIGINAL CONTRIBUTION Early Stroke Risk After Transient Ischemic Attack Among Individuals With Symptomatic Intracranial Artery Stenosis Bruce Ovbiagele, MD; Salvador Cruz-Flores, MD; Michael J. Lynn, MS;
More informationCEREBRO VASCULAR ACCIDENTS
CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA
More informationORIGINAL CONTRIBUTION. Long-term Risk of Stroke and Other Vascular Events in Patients With Asymptomatic Carotid Artery Stenosis
ORIGINAL CONTRIBUTION Long-term Risk of Stroke and Other Vascular Events in Patients With Asymptomatic Carotid Artery Stenosis Zurab G. Nadareishvili, MD, PhD; Peter M. Rothwell, MD, PhD; Vadim Beletsky,
More informationEarly neurological worsening in acute ischaemic stroke patients
Acta Neurol Scand 2016: 133: 25 29 DOI: 10.1111/ane.12418 2015 The Authors. Acta Neurologica Scandinavica Published by John Wiley & Sons Ltd ACTA NEUROLOGICA SCANDINAVICA Early neurological in acute ischaemic
More informationWHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.
WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:
More informationSpeakers. 2015, American Heart Association 1
Speakers Lee Schwamm, MD, FAHA Executive Vice Chairman of Neurology, Massachusetts General Hospital Director, Stroke Service and Medical Director, MGH TeleHealth, Massachusetts General Hospital Director,
More informationComparison of Five Major Recent Endovascular Treatment Trials
Comparison of Five Major Recent Endovascular Treatment Trials Sample size 500 # sites 70 (100 planned) 316 (500 planned) 196 (833 estimated) 206 (690 planned) 16 10 22 39 4 Treatment contrasts Baseline
More informationTIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea
TIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea R. Pini, G.L. Faggioli, M. Gargiulo, E. Pisano, A. Pilato, E. Gallitto, C. Mascoli, L.M. Cacioppa, A. Vacirca,
More informationCryptogenic Strokes: Evaluation and Management
Cryptogenic Strokes: Evaluation and Management 77 yo man with hypertension and hyperlipidemia developed onset of left hemiparesis and right gaze preference, last seen normal at 10:00 AM Brought to ZSFG
More informationManagement and Investigation of Ischemic Stroke By Etiology
Management and Investigation of Ischemic Stroke By Etiology Andrew M. Demchuk MD FRCPC Director, Calgary Stroke Program Deputy Dept Head, Clinical Neurosciences Heart and Stroke Foundation Chair in Stroke
More informationOpen Access The Addition of MRI to CT Based Stroke and TIA Evaluation Does Not Impact One year Outcomes
Send Orders of Reprints at reprints@benthamscience.net The Open Neurology Journal, 2013, 7, 17-22 17 Open Access The Addition of MRI to CT Based Stroke and TIA Evaluation Does Not Impact One year Outcomes
More informationCAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough
Todd W GenslerMD April 28, 2018 CAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough DISCLOSURES I have no financial disclosures Presenter name
More informationLuminal thrombosis in middle cerebral artery occlusions: a highresolution
Original Article Page 1 of 6 Luminal thrombosis in middle cerebral artery occlusions: a highresolution MRI study Wei-Hai Xu 1 *, Ming-Li Li 2 *, Jing-Wen Niu 1, Feng Feng 2, Zheng-Yu Jin 2, Shan Gao 1
More informationPFO Management update
PFO Management update May 12, 2017 Peter Casterella, MD Swedish Heart and Vascular 1 PFO Update 2017: Objectives Review recently released late outcomes of RESPECT trial and subsequent FDA approval of PFO
More informationThe randomized study of efficiency and safety of antithrombotic therapy in
.. [ ] 18 150 160 mg/d 2 mg/d INR 2.0 3.0( 75 INR 1.6 2.5) 704 369 335 420 59.7% 63.3 9.9 19 2 24 2.7% 6.0% P =0.03 OR 0.44 95% CI 0.198 0.960 56% 62% 1.8% 4.6% P =0.04 OR 0.38 95% CI 0.147 0.977 52% 10.6%
More informationThe learning curve associated with intracranial angioplasty and stenting: analysis from a single center
Original Article Page 1 of 7 The learning curve associated with intracranial angioplasty and stenting: analysis from a single center Peiquan Zhou, Guang Zhang, Zhiyong Ji, Shancai Xu, Huaizhang Shi Department
More informationLong-Term Care Updates
Long-Term Care Updates October/November 2015 By Daniel Kerner, PharmD A stroke occurs when blood flow to the brain is stopped or slowed, resulting in death or damage to brain cells. There are three main
More information[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]
2015 PHYSICIAN SIGN-OFF (1) STUDY NO (PHY-1) CASE, PER PHYSICIAN REVIEW 1=yes 2=no [strictly meets case definition] (PHY-1a) CASE, IN PHYSICIAN S OPINION 1=yes 2=no (PHY-2) (PHY-3) [based on all available
More informationComorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia
Supplementary Table S1 International Classification of Disease 10 (ICD-10) codes Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care I48 AF
More informationDr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre
Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre Objectives To learn what s new in stroke care 2010-11 1) Acute stroke management Carotid artery stenting versus surgery for symptomatic
More informationDoes ABCD 2 Score Below 4 Allow More Time to Evaluate Patients With a Transient Ischemic Attack?
Does Below 4 Allow More Time to Evaluate Patients With a Transient Ischemic Attack? Pierre Amarenco, MD; Julien Labreuche, BS; Philippa C. Lavallée, MD; Elena Meseguer, MD; Lucie Cabrejo, MD; Tarik Slaoui,
More informationUpdated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary
SOCIETY FOR VASCULAR SURGERY DOCUMENT Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary John J. Ricotta, MD, a Ali AbuRahma, MD, FACS, b
More informationSubclavian artery Stenting
Subclavian artery Stenting Etiology Atherosclerosis Takayasu s arteritis Fibromuscular dysplasia Giant Cell Arteritis Radiation-induced Vascular Injury Thoracic Outlet Syndrome Neurofibromatosis Incidence
More informationCritical Review Form Therapy
Critical Review Form Therapy A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects, Lancet-Neurology 2007; 6: 953-960 Objectives: To evaluate the effect of
More informationEmergently? Michigan Institute for Neurological Disorders. Garden City Hospital, Garden City, Michigan
Why Should TIA be Treated Emergently? Anne M. Pawlak, D.O. F.A.C.N. Michigan Institute for Neurological Disorders Director Neurology Residency Program, Garden City Hospital, Garden City, Michigan According
More informationManagement of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis
Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis Tim Mikesell, D.O. Oct 22, 2016 Stroke facts Despite progress in decreasing stroke incidence and mortality, stroke
More informationIschemic Stroke in Critically Ill Patients with Malignancy
Ischemic Stroke in Critically Ill Patients with Malignancy Jeong-Am Ryu 1, Oh Young Bang 2, Daesang Lee 1, Jinkyeong Park 1, Jeong Hoon Yang 1, Gee Young Suh 1, Joongbum Cho 1, Chi Ryang Chung 1, Chi-Min
More informationTRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES
TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES ALBERTO MAUD, MD ASSOCIATE PROFESSOR TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER EL PASO PAUL L. FOSTER SCHOOL OF MEDICINE 18TH ANNUAL RIO GRANDE TRAUMA 2017
More informationPolicies and Statements D16. Intracranial Cerebrovascular Ultrasound
Policies and Statements D16 Intracranial Cerebrovascular Ultrasound SECTION 1: INSTRUMENTATION Policies and Statements D16 Intracranial Cerebrovascular Ultrasound May 2006 (Reaffirmed July 2007) Essential
More informationTill Blaser, MD; Wenzel Glanz; Stephan Krueger, MD; Claus-Werner Wallesch, MD; Siegfried Kropf, PhD; Michael Goertler, MD
Time Period Required for Transcranial Doppler Monitoring of Embolic Signals to Predict Recurrent Risk of Embolic Transient Ischemic Attack and Stroke From Arterial Stenosis Till Blaser, MD; Wenzel Glanz;
More informationVivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine
Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Institute The Oregon Clinic Disclosure I declare that neither
More informationRetrospective Study on the Safety and Efficacy of Clopidogrel in the Treatment of Acute Cerebral Infarction
International Journal of Neurologic Physical Therapy 2018; 4(1): 24-28 http://www.sciencepublishinggroup.com/j/ijnpt doi: 10.11648/j.ijnpt.20180401.14 ISSN: 2575-176X (Print); ISSN: 2575-1778 (Online)
More informationSupplementary Online Content
1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing
More informationSecondary Stroke Prevention: A Precautionary Tale
Secondary Stroke Prevention: A Precautionary Tale Kirsten George-Phillips, BSP Clinical Practice Leader, AHS Clinical Pharmacist, AHS Owen Stroke Prevention Clinic Learning Objectives! Examine literature
More informationCerebrovascular disease among Chinese populations recent epidemiological and neuroimaging studies
SEMINAR PAPER KS Wong YN Huang S Gao ==== WWM Lam YL Chan Cerebrovascular disease among Chinese populations recent epidemiological and neuroimaging studies!"#$%&'()*%+,-./012 Stroke mortality in individuals
More information5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016
Outpatient Stroke Management Sheila Smith MD May 5, 2016 1 Management of Outpatient Stroke Objectives Review blood pressure management post stroke Review antithrombotic therapy Review statin therapy Discuss
More informationEffect of Having a PFO Occlusion Device in Place in the RESPECT PFO Closure Trial
Effect of Having a PFO Occlusion Device in Place in the RESPECT PFO Closure Trial DAVID E. THALER, MD, PHD, JEFFREY L. SAVER, MD RICHARD W. SMALLING, MD, PHD, JOHN D. CARROLL, MD, SCOTT BERRY, PHD, LEE
More informationAntiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.
Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.Κιλκίς Primary CVD Prevention A co-ordinated set of actions,
More informationTHE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease
THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS 1. Cardiovascular Disease Cardiovascular disease is considered to have developed if there was a definite manifestation
More informationStroke/Carotid Artery Disease Outcome Detail (Form 121/132)
In Ext2 these outcomes are only adjudicated for Medical Record Cohort (MRC) ppts. ID WHI Participant Common ID Col#1 ASCSOURCE Ascertainment Source Col#2 1 Local Form 121 1,112 14.4 2 Central Form 121
More informationDo Not Cite. Draft for Work Group Review.
Defect Free Acute Inpatient Ischemic Stroke Measure Bundle Measure Description Percentage of patients aged 18 years and older with a diagnosis of ischemic stroke OR transient ischemic attack who were admitted
More informationPractical Considerations in the Early Treatment of Acute Stroke
Practical Considerations in the Early Treatment of Acute Stroke Matthew E. Fink, MD Neurologist-in-Chief Weill Cornell Medical College New York-Presbyterian Hospital mfink@med.cornell.edu Disclosures Consultant
More informationKEEPING YOUR PATIENT OUT OF THE HOSPITAL BY PREVENTING A SECOND STROKE
KEEPING YOUR PATIENT OUT OF THE HOSPITAL BY PREVENTING A SECOND STROKE Dr. Grant Stotts Staff Neurologist, Ottawa Hospital Director, Ottawa Stroke Program Medical Director, Champlain Regional Stroke Program
More informationPrimary Stroke Center Quality & Performance Measures
Primary Stroke Center Quality & Performance Measures This section of the manual contains information related to the quality performance of Primary Stroke Centers. Brain Attack Coalition Definitions Recognition
More informationThe Effect of Diagnostic Catheter Angiography on Outcomes of Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment
The Effect of Diagnostic Catheter Angiography on Outcomes of Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment Adnan I. Qureshi, MD 1, Muhammad A. Saleem, MD 1, Emrah Aytaç, MD
More informationIschaemic cardiovascular disease
Ischaemic cardiovascular disease What are the PHO performance programme indicators and how are they best achieved? 40 BPJ Issue 36 Supporting the PHO Performance Programme The PHO Performance Programme
More informationProlonged TCD Monitoring for Microembolus Detection in Acute Stroke Patients
M. A. Etrebi et al. Prolonged TCD Monitoring for Microembolus Detection in Acute Stroke Patients M. A. Etrebi 1, Nevine El Nahas 1, Hanaa Abdel Kader 2, Mona T. El-Ghoneimy 3 Departments of Neurology 1,
More informationAnticoagulants and Head Injuries. Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar
Anticoagulants and Head Injuries Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar Common Anticoagulants and Indications Coumadin (warfarin) indicated for
More informationMORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance
MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1
More informationStroke secondary prevention. Gill Cluckie Stroke Nurse Consultant St. George s Hospital
Stroke secondary prevention Gill Cluckie Stroke Nurse Consultant St. George s Hospital Stroke recurrence The risk of recurrent stroke is greatest after first stroke 2 3% of survivors of a first stroke
More informationIndex. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACAS (Asymptomatic Carotid Atherosclerosis Study), 65 66 ACST (Asymptomatic Carotid Surgery Trial), 6 7, 65, 75 Age factors, in carotid
More informationProtokollanhang zur SPACE-2-Studie Neurology Quality Standards
Protokollanhang zur SPACE-2-Studie Neurology Quality Standards 1. General remarks In contrast to SPACE-1, the neurological center participating in the SPACE-2 trial will also be involved in the treatment
More informationEmergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates)
2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates) Summary of Changes I62.9 added to hemorrhagic stroke ICD-10-CM diagnosis code list (table 3) Measure Description Methodology Rationale Measurement
More informationTIA triage in Not all that glitters is gold
TIA triage in 2016 Not all that glitters is gold Disclosures No industry related disclosures Expert witness work Overview Definition Implications Guidelines, secondary prevention Implementation of guidelines
More informationLearning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship
Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship CLINICAL PROBLEMS IN VASCULAR SURGERY 1. ABDOMINAL AORTIC ANEURYSM A 70 year old man presents in the emergency department with
More informationHEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM
REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,
More informationCurrent role of low molecular weight heparin in the treatment of acute. ischemic stroke.
International Journal of Advances in Medicine Singh K. Int J Adv Med. 2017 Dec;4(6):1599-1604 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20175174
More informationStroke/Carotid Artery Disease Outcome Detail (Form 121/132, CaD ppts)
This file contains outcomes collected through the end of Ext1. ID WHI Participant Common ID Col#1 N Missing 0 ASCSOURCE Ascertainment Source Col#2 1 Local Form 121 241 14.9 2 Central Form 121 112 6.9 3
More informationClinical Study Circle of Willis Variants: Fetal PCA
Stroke Research and Treatment Volume 2013, Article ID 105937, 6 pages http://dx.doi.org/10.1155/2013/105937 Clinical Study Circle of Willis Variants: Fetal PCA Amir Shaban, 1 Karen C. Albright, 2,3,4,5
More informationLIBERTY 360 Study. 15-Jun-2018 Data 1. Olinic Dm, et al. Int Angiol. 2018;37:
LIBERTY 360 Study LIBERTY is a prospective, observational, multi-center study to evaluate procedural and long-term clinical and economic outcomes of endovascular device interventions in patients with symptomatic
More informationRelationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome
Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João
More informationSection Editor Scott E Kasner, MD
1 of 6 9/29/2013 6:55 PM Official reprint from UpToDate www.uptodate.com 2013 UpToDate The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis,
More informationA common clinical dilemma. Ischaemic stroke or TIA with atrial fibrillation MRI scan with blood-sensitive imaging shows cerebral microbleeds
Cerebral microbleeds and intracranial haemorrhage risk in patients with atrial fibrillation after acute ischaemic stroke or transient ischaemic attack: multicentre observational cohort study D. Wilson,
More informationThrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE
Thrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE ESUS Progression of haematoma Anticoagulation Large ICH
More informationRadiologic Importance of a High- Resistive Vertebral Artery Doppler Waveform on Carotid Duplex Ultrasonography
CME Article Radiologic Importance of a High- Resistive Vertebral Artery Doppler Waveform on Carotid Duplex Ultrasonography Esther S. H. Kim, MD, MPH, Megan Thompson, Kristine M. Nacion, BA, Carmel Celestin,
More informationICSS Safety Results NOT for PUBLICATION. June 2009 ICSS ICSS ICSS ICSS. International Carotid Stenting Study: Main Inclusion Criteria
Safety Results NOT for The following slides were presented to the Investigators Meeting on 22/05/09 and most of them were also presented at the European Stroke Conference on 27/05/09 They are NOT for in
More informationIntracranial Atherosclerosis: Pathophysiology, Diagnosis and Treatment
Intracranial Atherosclerosis: Pathophysiology, Diagnosis and Treatment Frontiers of Neurology and Neuroscience Vol. 40 Series Editor J. Bogousslavsky Montreux Intracranial Atherosclerosis: Pathophysiology,
More informationSubclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study
Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study Meagan Sullivan, PharmD PGY2 Cardiology Pharmacy Resident University of Chicago Medicine
More informationStroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%
Stroke Update Michel Torbey, MD, MPH, FAHA, FNCS Medical Director, Neurovascular Stroke Center Professor Department of Neurology and Neurosurgery The Ohio State University Wexner Medical Center Objectives
More informationCerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11
Cerebrovascular Disorders Blood, Brain, and Energy 20% of body s oxygen usage No oxygen/glucose reserves Hypoxia - reduced oxygen Anoxia - Absence of oxygen supply Cell death can occur in as little as
More informationVertebrobasilar Insufficiency
Equilibrium Res Vol. (3) Vertebrobasilar Insufficiency Toshiaki Yamanaka Department of Otolaryngology-Head and Neck Surgery, Nara Medical University School of Medicine Vertebrobasilar insufficiency (VBI)
More information